Government research grant outsourced by MFDS : ‘Development of evaluation technology for quality and safety of immuno-oncology cell-based gene therapy’
2021
12
Awarded by the Korean Minister of SMEs and Startups
(‘Promoting startups 2021’)
Initiation meeting for two Phase 1 clinical trials of DMD and CMT
11
Awarded by the Korean Minister of Health and Welfare
(‘Healthcare technology advancement 2021’)
10
Completion of 2nd GMP Plant Construction
06
IND Approval for Phase 1 Clinical Trial of Charcot-Marie-Tooth Disease
‘Cell Processing Facility’ Approval by MFDS (KFDA)
05
IND Approval for Phase 1 Clinical Trial of Duchenne Muscular Dystrophy
Designated as Cell Processing Center (CPC) for KYMRIAH® ‘(Novartis)
Series B Investment (22.4 million USD) Secured
03
‘Human Cell Management Business’ Approval by MFDS (KFDA)
01
Designated as Central Cell Processing Center (CCPC) for Car-T Product of Janssen
2020
09
Awarded as “Innovative Biotech Company in Excellent Progress”
by the Ministry of Trade, Industry and Energy of Korea
08
ISO 9001:2015 Certificate Received by KFDA – Our 1st GMP Plant (Seoul)
07
R&D Project Collaborated with Small and Medium Business Administration of Korea Granted
06
Strategic Partnership with ThermoFisher Scientific™
02
Series A Investment (8.8 million USD) Secured
GMP System Design and Establishment Started
2019
08
2nd GMP Plant Site Purchased
07
Awarded as “Company with Outstanding Performance”
by Korea Health Industry Development Institute
2018
08
GMP Declaration Issued by MFDS(KFDA)
07
TIPS Program Granted
(R&D Grant by Korean Ministry of SMEs and Startups)
05
Signed a Contract Providing CMO Services for
Anticancer Gene-modified MSC Therapy with Hanmi Pharmaceuticals
03
Corporation Establishment
[Headquarters] 6th Floor, W Tower (Cheongdam-dong)
[1st GMP Plant] B3 Future Medicine Hall, Samsung Medical Center
02
Founded ENCell as Faculty Startup in Samsung Medical Center